Fund Holdings — Cutter Capital Management, LP

Total Portfolio Value:
$338.79M
Total Bought:
$186.99M
Total Sold:
$181.88M
Net Transaction:
+$5.11M
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Gilead Sciences, Inc.(GILD)292,959359,025+66,066$20.10M$30.10M8.88%+$10.00M
Bristol-Myers Squibb Company(BMY)0574,057+574,057$0$29.70M8.77%+$29.70M
Royalty Pharma plcCL A(RPRX)692,300664,859-27,441$18.26M$18.81M5.55%+$552.9K
Agilent Technologies, Inc.(A)0120,485+120,485$0$17.89M5.28%+$17.89M
Ultragenyx Pharmaceutical Inc.(RARE)365,000286,803-78,197$15.00M$15.93M4.70%+$930.4K
Legend Biotech CorporationADS(LEGN)343,130325,953-17,177$15.20M$15.88M4.69%+$686.5K
Insmed Incorporated(INSM)227,637215,884-11,753$15.25M$15.76M4.65%+$507.9K
Eli Lilly and Company(LLY)017,299+17,299$0$15.33M4.52%+$15.33M
Regeneron Pharmaceuticals, Inc.(REGN)014,476+14,476$0$15.22M4.49%+$15.22M
Harmony Biosciences Holdings, Inc.(HRMY)295,771376,315+80,544$8.92M$15.05M4.44%+$6.13M
Perrigo Company plcSHS(PRGO)100,000557,937+457,937$2.57M$14.63M4.32%+$12.07M
Jazz Pharmaceuticals plcSHS USD(JAZZ)0117,500+117,500$0$13.09M3.86%+$13.09M
Springworks Therapeutics Inc0378,453+378,453$0$12.13M3.58%+$12.13M
Viridian Therapeutics, Inc.(VRDN)0518,677+518,677$0$11.80M3.48%+$11.80M
Sarepta Therapeutics, Inc.(SRPT)89,37983,756-5,623$14.12M$10.46M3.09%-$3.66M
BridgeBio Pharma, Inc.(BBIO)311,700396,388+84,688$7.90M$10.09M2.98%+$2.20M
Axsome Therapeutics, Inc.(AXSM)0105,767+105,767$0$9.51M2.81%+$9.51M
Agios Pharmaceuticals, Inc.(AGIO)0186,623+186,623$0$8.29M2.45%+$8.29M
Iovance Biotherapeutics, Inc.(IOVA)0876,009+876,009$0$8.23M2.43%+$8.23M
Intellia Therapeutics, Inc.(NTLA)0390,622+390,622$0$8.03M2.37%+$8.03M
Vera Therapeutics, Inc.CL A(VERA)230,000172,876-57,124$8.32M$7.64M2.26%-$680.3K
Arcellx Inc
COMMON STOCK
187,00089,863-97,137$10.32M$7.50M2.22%-$2.82M
Avidity Biosciences Inc0160,947+160,947$0$7.39M2.18%+$7.39M
BioCryst Pharmaceuticals, Inc.(BCRX)1,975,298798,137-1,177,161$12.21M$6.07M1.79%-$6.14M
Enliven Therapeutics Inc222,985207,896-15,089$5.21M$5.31M1.57%+$98.5K
Avadel Pharmaceuticals Plc733,001385,172-347,829$10.31M$5.05M1.49%-$5.25M
Ionis Pharmaceuticals, Inc.(IONS)160,16697,300-62,866$7.63M$3.90M1.15%-$3.74M
Amgen Inc.(AMGN)64,2010-64,201$20.06M$0—-$20.06M
Avantor, Inc.(AVTR)400,0000-400,000$8.48M$0—-$8.48M
Biogen Inc.(BIIB)76,7260-76,726$17.79M$0—-$17.79M
BioMarin Pharmaceutical Inc.(BMRN)273,5330-273,533$22.52M$0—-$22.52M
CRISPR Therapeutics AGNAMEN AKT(CRSP)201,4970-201,497$10.88M$0—-$10.88M
Cytokinetics, Incorporated(CYTK)236,9000-236,900$12.84M$0—-$12.84M
Evolus, Inc.(EOLS)465,3000-465,300$5.05M$0—-$5.05M
Kenvue Inc.(KVUE)960,4000-960,400$17.46M$0—-$17.46M
Merck & Co., Inc.(MRK)175,6000-175,600$21.74M$0—-$21.74M
Pfizer Inc.(PFE)185,2000-185,200$5.18M$0—-$5.18M
Teva Pharmaceutical Industries LimitedADS(TEVA)911,9000-911,900$14.82M$0—-$14.82M
Page 1 of 1
Cutter Capital Management, LP — 13F Holdings — Q3 2024 | TickerTrail